1. Home
  2. CELU vs MIND Comparison

CELU vs MIND Comparison

Compare CELU & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • MIND
  • Stock Information
  • Founded
  • CELU 2016
  • MIND 1987
  • Country
  • CELU United States
  • MIND United States
  • Employees
  • CELU N/A
  • MIND N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • MIND Industrial Machinery/Components
  • Sector
  • CELU Health Care
  • MIND Industrials
  • Exchange
  • CELU Nasdaq
  • MIND Nasdaq
  • Market Cap
  • CELU 42.2M
  • MIND 40.6M
  • IPO Year
  • CELU N/A
  • MIND 1994
  • Fundamental
  • Price
  • CELU $1.61
  • MIND $6.53
  • Analyst Decision
  • CELU
  • MIND
  • Analyst Count
  • CELU 0
  • MIND 0
  • Target Price
  • CELU N/A
  • MIND N/A
  • AVG Volume (30 Days)
  • CELU 54.8K
  • MIND 225.8K
  • Earning Date
  • CELU 12-06-2024
  • MIND 04-22-2025
  • Dividend Yield
  • CELU N/A
  • MIND N/A
  • EPS Growth
  • CELU N/A
  • MIND N/A
  • EPS
  • CELU N/A
  • MIND 4.32
  • Revenue
  • CELU $48,200,000.00
  • MIND $46,863,000.00
  • Revenue This Year
  • CELU N/A
  • MIND $22.98
  • Revenue Next Year
  • CELU $233.89
  • MIND $10.18
  • P/E Ratio
  • CELU N/A
  • MIND $1.51
  • Revenue Growth
  • CELU 225.94
  • MIND 28.36
  • 52 Week Low
  • CELU $1.00
  • MIND $3.05
  • 52 Week High
  • CELU $5.22
  • MIND $11.10
  • Technical
  • Relative Strength Index (RSI)
  • CELU 49.49
  • MIND 57.79
  • Support Level
  • CELU $1.47
  • MIND $6.15
  • Resistance Level
  • CELU $1.77
  • MIND $7.45
  • Average True Range (ATR)
  • CELU 0.16
  • MIND 0.51
  • MACD
  • CELU 0.01
  • MIND 0.29
  • Stochastic Oscillator
  • CELU 63.04
  • MIND 69.33

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.

Share on Social Networks: